Literature DB >> 11888686

Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions.

Shilpa P Deshpande1, Mei Zheng, Sujin Lee, Barry T Rouse.   

Abstract

This article reviews possible mechanisms by which ocular infections with herpes simplex virus result in a blinding immunoinflammatory lesion in the cornea. We conclude that this immunoinflammatory response involves multiple immune mechanisms including autoimmunity.

Entities:  

Mesh：

Year:  2002        PMID： 11888686     DOI： 10.1016/s0378-1135(01)00487-4

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN： 0378-1135            Impact factor:   3.293


  13 in total

1.  Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1.

Authors:  Naveen K Rajasagi; Pradeep B J Reddy; Amol Suryawanshi; Sachin Mulik; Per Gjorstrup; Barry T Rouse
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

2.  Prior Corneal Scarification and Injection of Immune Serum are Not Required Before Ocular HSV-1 Infection for UV-B-Induced Virus Reactivation and Recurrent Herpetic Corneal Disease in Latently Infected Mice.

Authors:  Lbachir BenMohamed; Nelson Osorio; Arif A Khan; Ruchi Srivastava; Lei Huang; John J Krochmal; Jairo M Garcia; Jennifer L Simpson; Steven L Wechsler
Journal:  Curr Eye Res       Date:  2015-09-23       Impact factor: 2.424

3.  Controlling herpetic stromal keratitis by modulating lymphotoxin-alpha-mediated inflammatory pathways.

Authors:  Tamara Veiga-Parga; Fernanda Giménez; Sachin Mulik; Eugene Y Chiang; Jane L Grogan; Barry T Rouse
Journal:  Microbes Infect       Date:  2013-07-10       Impact factor: 2.700

4.  Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea.

Authors:  Katarina Polcicova; Partha Sarathi Biswas; Kaustuv Banerjee; Todd W Wisner; Barry T Rouse; David C Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

5.  Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis.

Authors:  Bumseok Kim; Qingquan Tang; Partha S Biswas; Jun Xu; Raymond M Schiffelers; Frank Y Xie; Aslam M Ansari; Puthupparampil V Scaria; Martin C Woodle; Patrick Lu; Barry T Rouse
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

6.  Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators.

Authors:  Sharvan Sehrawat; Amol Suryawanshi; Mitsuomi Hirashima; Barry T Rouse
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 7.  Potential function of miRNAs in herpetic stromal keratitis.

Authors:  Sachin Mulik; Siddheshvar Bhela; Barry T Rouse
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-17       Impact factor: 4.799

8.  Curcumin inhibits angiogenesis by up-regulation of microRNA-1275 and microRNA-1246: a promising therapy for treatment of corneal neovascularization.

Authors:  Yanhui Bai; Weiqun Wang; Guangli Sun; Mingchang Zhang; Jingmin Dong
Journal:  Cell Prolif       Date:  2016-09-14       Impact factor: 6.831

9.  Host responses to wild-type and attenuated herpes simplex virus infection in the absence of Stat1.

Authors:  Tracy Jo Pasieka; Cristian Cilloniz; Betty Lu; Thomas H Teal; Sean C Proll; Michael G Katze; David A Leib
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

10.  Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice.

Authors:  C M Richards; R Case; T R Hirst; T J Hill; N A Williams
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.